MOMA Therapeutics
MOMA Therapeutics is a Cambridge, Massachusetts drug-discovery company founded in 2020 that builds precision medicines against molecular machines — the highly dynamic proteins that convert chemical energy stored in cells into regulatory work such as protein transport, DNA repair and degradation, and whose constant conformational shape-shifting has historically made them undruggable. Its proprietary KNOMATIC platform combines advanced structural frameworks and functional-genomics target validation with high-throughput fragment and DNA-encoded-library screening, CRISPR gene editing, artificial intelligence for detecting dynamic conformational patterns, and machine-learning lead optimisation, all built against a continually expanding structure-function knowledge base. The company launched in April 2020 with an $86 million Series A led by Third Rock Ventures, added a $150 million Series B in May 2022, and has taken two wholly owned oncology assets into the clinic: MOMA-313, a selective inhibitor of the polymerase theta (Polθ) helicase domain for homologous- recombination-deficient tumours, which entered Phase 1 in August 2024; and MOMA-341, a potent and selective WRN helicase inhibitor for microsatellite-unstable and TA-repeat-expanded tumours, which dosed its first Phase 1 patient in July 2025. It also runs a five-year discovery collaboration with Roche announced in January 2024, an oncology collaboration and licence agreement with Bayer signed in October 2024, and an exclusive licence for a selective PARP1 inhibitor announced in January 2025. MOMA Therapeutics runs no developer program and publishes no product API, developer portal, API reference or machine-readable specification. The only machine-readable surface reachable without credentials is the WordPress REST content API behind momatx.com, catalogued here.
Limited machine-readable signal and partial portal coverage — documentation a human can read, but little a machine or agent can consume without scraping.
API Evangelist profiles MOMA Therapeutics the way a machine reads it — 14 machine-readable artifacts across 10 APIs, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — MOMA Therapeutics scores 32.3/100 (thin), with a separate agent-readiness read of 24/100 (agent aware). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance. Every facet and dimension name is a link: it opens that measurement's page on APIs.io, where the rating runs across the whole catalog — the exact checks that feed it, how every profiled provider distributes on it, and who is at the top of it.
Kin Score
How this is scored →scored 2026-09-01 · rubric v0.18.0
Put this on your own site. The badge is drawn live from MOMA Therapeutics's current Kin Score — paste it once and it updates itself every time the score is recomputed. It follows your visitor's light or dark setting, and it links back here so anyone who sees it can read the full breakdown.
<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/moma-therapeutics/"
title="MOMA Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/moma-therapeutics.svg"
alt="MOMA Therapeutics Kin Score — API readiness rating by API Evangelist" width="150" height="150" loading="lazy">
</a>[](https://providers.apievangelist.com/providers/moma-therapeutics/)<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/moma-therapeutics/"
title="MOMA Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/moma-therapeutics/card.svg"
alt="MOMA Therapeutics Kin Score — API readiness rating by API Evangelist" width="340" height="120" loading="lazy">
</a>More shapes, themes and sizes → · Score as JSON · How badges work
How we profile MOMA Therapeutics
Each block below is one kind of artifact we hold for MOMA Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
APIs 10
Each API is captured as its own OpenAPI definition — every operation, parameter, and response. This is the single most useful machine-readable description of what an API does, and it's what lets us score, lint, mock, and generate against it without asking the provider for anything.
Individual APIs this provider publishes, each with its own machine-readable definition.
MOMA Therapeutics Content Posts API
News archive — company press releases, media coverage, peer-reviewed publications and conference presentations (32 published at harvest time, spanning April 2020 through August ...
MOMA Therapeutics Content Pages API
Corporate pages — Science, Pipeline, MOMA, Team, Join Us, News Feed, Privacy Policy and Terms (9 published at harvest time). The acf.modules flexible-content array carries the p...
MOMA Therapeutics Team API
The team custom post type — leadership, board of directors, scientific advisory board and founders (59 published records at harvest time), classified by the MOMA-specific team_t...
MOMA Therapeutics Media API
Media library — AACR conference posters, publication PDFs, headshots, logos and site imagery (211 attachments at harvest time).
MOMA Therapeutics Taxonomy API
Term collections for the three registered taxonomies — category (4 terms including Blog and Press Release), post_tag (registered but empty) and the MOMA-specific team_types (3 t...
MOMA Therapeutics Discovery API
Self-describing metadata — the 219-route index across 12 namespaces, plus registered post types, taxonomies and statuses. This is the only machine-readable contract the company ...
MOMA Therapeutics Search API
Cross-content search over every published object — posts, pages and team records. An unfiltered query returned 42 results at harvest time.
MOMA Therapeutics Comments API
Comment collection. Registered and anonymously reachable, but empty — no object on this deployment carries comments.
MOMA Therapeutics oEmbed API
oEmbed 1.0 provider endpoint for momatx.com URLs, returning rich embeddable responses.
MOMA Therapeutics Site Options API
Advanced Custom Fields options-page payload, anonymously readable at /acf/v3/options/options. It carries site-wide configuration — logo, footer contact block, social profile URL...
Scroll within the panel for all 10 ·
Pricing Plans 1
Pricing is part of the interface. Machine-readable plans tell you what a tier costs and includes before you commit — one of the things the Kin Score reads for access clarity — renamed from commercial clarity in rubric 0.12, because a free statutory interface has access terms and no commercial ones.
Published pricing tiers and plan structures.
Rate Limits 1
Rate limits are the difference between a demo that works and a production integration that doesn't fall over. Publishing them is an operational-transparency signal — and a hard requirement for any agent that plans its own throughput.
Documented rate limits and quota policies.
Moma Therapeutics Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for MOMA Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Learn 1
Tutorials, courses, talks, and written guidance
Operate 2
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 8
The organization behind the API
Scroll within the panel for all 8 ·
Other 4
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/moma-therapeutics · machine-readable index on apis.io
This is an independent, third-party profile of MOMA Therapeutics, published by API Evangelist. We do not operate, host, resell, or support these APIs, and we are not affiliated with or endorsed by the company unless stated above. Everything here is built from publicly available information — the company's own site, developer portal, documentation, public repositories, and the specifications it publishes for public use. Nothing is obtained by breaching a system, defeating an access control, or using credentials.
The Kin Score and Agent Readiness rating are independently calculated assessments of a company's public API artifacts, scored against a published rubric. They are not certifications, endorsements, security assessments, or audits.
Corrections, re-scores, and removal are free — no partnership or purchase required, and you do not need to justify the request. A removed company is recorded as unrated, never scored zero for having asked. Acknowledgement within one business day; removal within two.
info@apievangelist.com
·
Read the full data-sourcing policy →
On a security or compliance team? Put security in the subject line and
you will get a person, not a form — we will tell you exactly which public URLs this profile was built from.